Haematology News/Publications

2003

• Jayandharan G, Shaji RV, Chandy M, Srivastava A. Identification of factor IX gene defects using a multiplex PCR and CSGE strategy – a first report.  J Thromb Haemost 2003; 1:2051-2053
• Shaji RV, Eunice SE, Baidya S, Srivastava A, Chandy M. Determination of the breakpoint and molecular diagnosis of a common alpha-thalassaemia-1 deletion in the Indian population. Br J Haematol. 2003; 123(5):942-947
• Srivastava A, Usher S, Nelson EJ, Jayandharan G, Shaji RV, Chandy M, Seligsohn U, Peretz H. Prenatal diagnosis of Glanzmann thrombasthenia. Natl Med J India. 2003; 16:207-208
• Srivastava A. Factor replacement therapy in haemophilia--Are there models for developing countries? Haemophilia. 2003; 9:391-396.
• Shaji RV, Edison ES, Poonkuzhali B, Srivastava A, Chandy M. Rapid detection of beta globin gene mutations and polymorphisms by temporal temperature gradient electrophoresis. Clin Chem 2003; 49:777-781
• Shaji RV, Edison ES, Krishnamoorthy R, Chandy M, Srivastava A. Hb Lepore in the Indian population. Hemoglobin. 2003; 27:7-14.
• Hanson P, Mathews V, Marrus SH, Graubert TA. Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp Hematol. 2003;31:159-167.
• Subhash HS, George B, Devi A, John G, Chandy M, Srivastava A. Patients with hematological disorders requiring admission to Medical Medical Intensive Care Unit Characteristics, Survival and Prognostic factors. IJCCM 2003; 7:2: 88 – 93
• Jayandharan G, Shaji RV, Chandy M, Srivastava A. Identification of factor IX gene defects using a multiplex PCR and CSGE strategy – A first report. J Thromb Haemost 2003; 1: 2051-2054.
• Subhash HS, George B, Devi A, John G, Chandy M, Srivastava A. Patients with hematological disorders requiring admission to Medical Intensive Care Unit  Characteristics, Survival and Prognostic factors. IJCCM 2003; 7:2: 88-93

2002

• Srivastava A, Mathews V, Bhurani D, Baidya S, Chandy M. Successful surgical hemostasis in patients with von Willebrand disease following infusion of KoateDVI. Thromb Haemost. 2002;87:541-543.
• Mathews V*, Balasubramanian P, Shaji RV, George B, Chandy M, Srivastava A. Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience. Am J Hematol. 2002;70:292-299.

<< Back to Archives